A+ A A-

Information Accessibility Statement
Site Colors Display (* Modern browsers like Chrome & Firefox) Normal Display Adjusted for color blinded Adjusted for hard vision Close

‹ › ×

Inbar Eizenkot

4th year, 4 year program

Dr. Einav Gal Yam, Breast Oncology Institute, Dr. Maya Dadiani, Breast Cancer Translational Research Laboratory

Subtype switch between primary and recurrent breast cancer: the underlying molecular mechanism and therapeutic implications

מוקד שירות אנגלית

Quality Metrics

donation - אתר אנגלית

MOVIES - אתר אנגלית